REVELATION BIOSCIENCES, INC. - REVB
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$636K
QoQ value delta ($000)
-$345K
(-35.17%)
Implied price effect (QoQ)
+44.53%
Shares
Total shares
552,216
QoQ shares delta
-678,826
(-55.14%)
Total shares held by funds (by quarter)
Market chart (REVB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 12 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 387 | 323,241 | 0.01% |
| SABBY MANAGEMENT, LLC | 119 | 99,432 | 0.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 51 | 43,195 | 0.0% |
| VANGUARD GROUP INC | 42 | 52,505 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 15 | 13,127 | 0.0% |
| XTX Topco Ltd | 13 | 11,385 | 0.0% |
| UBS Group AG | 4 | 4,115 | 0.0% |
| Tower Research Capital LLC (TRC) | 4 | 4,074 | 0.0% |
| ROYAL BANK OF CANADA | 1 | 747 | 0.0% |
| BNP Paribas Asset Management Holding S.A. | 0 | 9 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 344 | 0.0% |
| HARBOUR INVESTMENTS, INC. | 0 | 41 | 0.0% |
| Caitong International Asset Management Co., Ltd | 0 | 1 | 0.0% |